Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL)
Company finances score (revenue, margins, returns) is near the top of its range.
CUVL scores higher than 75% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) scores 54 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.08× 30-day average
- 52-week range
- —
- Market cap
- —
- Earnings date
- —
- Dividend yield
- 0.29%
- Volume
- 1,622
- Avg. volume (30d)
- 19,546
- Open
- 5.56
- Previous close
- 5.60
- Day's range (regular session)
- 5.56 – 5.59
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.27
- P/E (TTM)
- 12.80
- EPS (TTM)
- 0.64
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about CUVL right now
Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) currently scores 54/100 on the Market Census six-factor composite, at the Average score level. CUVL is -0.18% on the day and -7.30% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in CUVL's data roughly balance out right now. CUVL's strongest factor is company finances at 87/100 — a very strong read on the company's own reported numbers. A high reading doesn't promise a near-term move. The weakest factor is Momentum at 44/100 — middling recent price moves. Low momentum + high trend often marks a base-building phase rather than a topping pattern.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See CUVL in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent CUVL news
Latest headlines that name Clinuvel Pharmaceuticals Limited American, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Clinuvel Pharmaceuticals Limited (CUVL) Q4 2026 Earnings Call TranscriptSeekingAlpha
- A decade of profitability provides foundation for CLINUVEL’s U.S. expansionGlobeNewswire Inc.
- CLINUVEL FY2026 Revenue Dips 1% To $94.0M From $95.0M, Cash Reserves Rise 12% To $252.1M Amid US Expansion PushBenzinga
- Clinuvel (NASDAQ:CUVL): A Quality Investing Screen StandoutChartMill
- CLINUVEL implements strategic reorganisation to refocus on U.S. marketsGlobeNewswire Inc.
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to CUVL’s 54, all within 1 point.
Sorted by closeness to CUVL’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.